Details of the Drug

General Information of Drug (ID: DMQ1Q37)

Drug Name
Megesterol acetate
Indication
Disease Entry ICD 11 Status REF
Atypical endometrial hyperplasia N.A. Approved [1]
Breast cancer 2C60-2C65 Approved [2]
Endometrial carcinoma N.A. Investigative [3]
Affected Organisms
Humans and other mammals
Cross-matching ID
PubChem CID
11683
UNII
TJ2M0FR8ES
DrugBank ID
DB00351
TTD ID
D02IRD
Drug Pharmacogenomic Perturbation (DPP)NEW Click to Jump to the Detailed DPP Information of This Drug
Drug ADMET Endpoint Profile (DAE)NEW Click to Jump to the Detailed DAE Information of This Drug
Combinatorial Drugs (CBD) Click to Jump to the Detailed CBD Information of This Drug
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 Fertility-sparing management for endometrial cancer: review of the literature. Minerva Med. 2021 Feb;112(1):55-69.
2 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
3 Megestrol acetate drives endometrial carcinoma cell senescence via interacting with progesterone receptor B/FOXO1 axis. Exp Biol Med (Maywood). 2021 Nov;246(21):2307-2316.